Back

Safety and efficacy of drug-eluting balloons in large coronary vessels: a lesion-level analysis of real-world PCI practice

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Coronary interventions: optimisation of percutaneous coronary intervention techniques and restenosis prevention Restenosis ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Lucas Hamann

Algarve University Hospital Center, Faro (Portugal)

2 More presentations in this session

Presentation thumbnail
Outcome of left main stent implantation: a randomized comparison between ultra-thin strut (Suprafex Cruz) and thin strut (SYNERGY) stent, a post-hoc sub-analysis of the Multivessel TALENT trial
Doctor N. Kanehama (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Risk of restenosis for in-stent restenosis and de novo lesions treated during the same percutaneous coronary intervention procedure
Doctor D. Lahu (DE)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary interventions: optimisation of percutaneous coronary intervention techniques and restenosis prevention

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Acute coronary syndrome vs chronic coronary syndrome drug-eluting balloon PCI: a lesion-level analysis of predictors and outcomes of target lesion failure
29 August 2026
thumbnail
Congress Presentation
Drug-coated balloon–only strategy versus drug-eluting stents in large-vessel complex PCI: a propensity-matched 3-year outcome analysis
29 August 2026
thumbnail
Congress Presentation
Restenosis patterns after percutaneous coronary intervention with drug-coated balloon for de novo coronary lesions as assessed by optical coherence tomography
29 August 2025
thumbnail
Congress Presentation
Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de dovo coronary lesions: A five-year analysis from the ORPKI Registry
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources